and Development of
Novel Eye Therapeutics
There is an unmet clinical need for more effective treatments to halt or reverse eye diseases that lead to blindness (like age-related macular degeneration, diabetic retinopathy, and corneal inflammation) with increasing prevalence as the EU population ages.
3D-NET establishes a European network of industry and academic partners, who exchange knowledge, people, and expertise to enhance the discovery and development of drugs that target these ocular pathologies (Funded by a FP7- Marie Curie IAPP grant).
Follow Us on Facebook, Twitter and LinkedIn
Marie Curie Industry-Academia Partnerships and Pathways (IAPP)
Project Number (612218/3D-NET)